REQUEST A DEMO
Total
USD $0.00
Search more companies

FKP Orlovskaya Biofabrika (ФКП Орловская Биофабрика) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: FKP Orlovskaya Biofabrika Profile Updated: October 18, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Russian Download a sample report

FKP Orlovskaya Biofabrika (ФКП Орловская Биофабрика) is based in Russia, with the head office in Oryol Oblast. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was established on December 19, 2002. The company’s latest financial report indicates a net sales revenue increase of 29.91% in 2024. Its’ total assets recorded a growth of 29.33%. The net profit margin of FKP Orlovskaya Biofabrika (ФКП Орловская Биофабрика) increased by 1.14% in 2024.

Headquarters
Biofabrika
Oryol Oblast; Oryol Oblast; Postal Code: 302501

Contact Details: Purchase the FKP Orlovskaya Biofabrika (ФКП Орловская Биофабрика) report to view the information.

Basic Information
Registered Capital:
Purchase the FKP Orlovskaya Biofabrika (ФКП Орловская Биофабрика) report to view the information.
Financial Auditors:
Purchase the FKP Orlovskaya Biofabrika (ФКП Орловская Биофабрика) report to view the information.
Incorporation Date:
December 19, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Rao Rosagrobioprom
0.23%
Company Performance
Financial values in the chart are available after FKP Orlovskaya Biofabrika (ФКП Орловская Биофабрика) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
29.91%
Total operating revenue
29.91%
Operating profit (EBIT)
54.87%
Net Profit (Loss) for the Period
39.93%
Total Assets
29.33%
Total Equity
28.24%
Operating Profit Margin (ROS)
4.42%
Net Profit Margin
1.14%
Return on Equity (ROE)
0.75%
Quick Ratio
0.97%
Cash Ratio
-1.68%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?